Mr. Daniel has more than 25 years of regulatory, clinical, and quality experience and has been a consultant for multiple medical device companies over the past 20 years.

Mr. Daniel is currently President of Daniel and Daniel Consulting, a leading West Coast medical device consulting firm that helps venture capital and angel funded companies bring products to market through the effective management of clinical study and regulatory processes.  He has familiarity with a broad range of medical devices, including: implantable heart assist devices (Novacor), in vitro diagnostics (SKD), endometrial resection/ablation devices (FemRx), coronary and peripheral catheters (LuMend, FHT, Kerberos), coronary anastomotic devices (Coalescent), left atrial appendage clips (LAAx) and general surgical implantable clips (Coalescent), implantable bronchial valves (Emphasis), gastrointestinal (GERD) and bariatric devices (Endogastric Solutions), femoral access closure devices (Cardiva) and endoscopic/percutaneous robotics (Intuitive Surgical, Hansen Medical, NeoGuide, ROBODOC).

Mr. Daniel holds a BS in Microbiology from Michigan State University, a MS in Biology from the Illinois Institute of Technology (IIT) and a MBA from the University of California, Berkeley.